Highly expressed carbohydrate sulfotransferase 11 correlates with unfavorable prognosis and immune evasion of hepatocellular carcinoma
Cancer Medicine · 2023-02 · 12 (4) · 4938-4950
DOI: 10.1002/cam4.5186 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 05.09.2022. Verfasst von Dan-Dan Xiong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, First Affiliated Hospital of Guangxi Medical University, Nanning, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Despite great advance has been made in multi‐modality treatments for HCC patients, the effectiveness is far from satisfactory with worse survival outcome, which may be partly explainable by the anti‐tumor deficiency of the immune system. It is necessary to clarify the molecular mechanism of HCC immunodeficiency. Here, we demonstrated that carbohydrate sulfotransferase 11 (CHST11) was upregulated in HCC and related to advanced TNM stage. HCC patients with TP53 mutation showed higher CHST11 expression. Survival analysis revealed that CHST11 was an independent prognostic biomarker in HCC. Cellular functional experiments indicated that knockdown of CHST11 in HCC inhibited cell proliferation and metastasis. Gene functional enrichment analyses indicated that CHST11 modulated pathways related to tumor growth, metastasis and immune regulation. Continuative immune‐related analyses revealed that CHST11 expression facilitated Tregs infiltration in HCC and promoted the expression of checkpoints PD‐L1/PD‐1, resulting in the immunosuppression of HCC. Targeting CHST11 may inhibit Tregs infiltration and enhance the antineoplastic effect of immune checkpoint inhibitors, which provides a novel insight into the combination immunotherapy with Treg‐modulating agents and PD‐L1/PD‐1 inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
- Department of Medical Oncology, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
ORCID-Profile: Gang Chen
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Xiong, D. D., Li, J. D., He, R. Q., Li, M. X., Pan, Y. Q., He, X. L., Dang, Y. W., & Chen, G. (2023). Highly expressed carbohydrate sulfotransferase 11 correlates with unfavorable prognosis and immune evasion of hepatocellular carcinoma. Cancer Medicine, 12(4), 4938-4950. https://doi.org/10.1002/cam4.5186
Vancouver
Xiong DD, Li JD, He RQ, Li MX, Pan YQ, He XL, et al. Highly expressed carbohydrate sulfotransferase 11 correlates with unfavorable prognosis and immune evasion of hepatocellular carcinoma. Cancer Medicine. 2023;12(4):4938-4950. doi:10.1002/cam4.5186
BibTeX
@article{Xiong2023,
author = {Xiong, Dan-Dan and Li, Jian-di and He, Rong-Quan and Li, Ming-Xuan and Pan, Yan-Qing and He, Xiao-Lian and Dang, Yi-Wu and Chen, Gang},
title = {Highly expressed carbohydrate sulfotransferase 11 correlates with unfavorable prognosis and immune evasion of hepatocellular carcinoma},
journal = {Cancer Medicine},
year = {2023},
volume = {12},
number = {4},
pages = {4938--4950},
doi = {10.1002/cam4.5186}
}
EUVIMED